Abstract: The present invention involves a method for prophylaxis or treatment of an animal for systemic hypotension induced by endotoxin and/or a biological response modifier such as the cytokines, IFN, TNF, IL-1 or IL-2 and the like. The method involves administering, preferably intravascularly, a therapeutically effective amount of dobutamine and an inhibitor of nitric oxide formation from arginine.
Type:
Grant
Filed:
March 31, 1995
Date of Patent:
July 7, 1998
Assignees:
Board of Regents, The University Of Texus System, Cornell Research Foundation, Inc.
Inventors:
Robert G. Kilbourn, Steven S. Gross, Owen W. Griffith